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here is increased interest in the use of constituent proteins and peptides to modulate T cell responses to comT
plex microbial and cellular antigens in situ. Typically, artificial
adjuvants are required. Several antigens are known to be immunogenic when administered in association with dendritic
cells but in the absence of additional adjuvants (1). The immunogenicity of dendritic cells in situ is apparent with contact allergens (2), transplantation antigens (3-6), and more
recently foreign proteins (7-9). The dendritic cells are serving
directly as APCs in situ, because the T cells that are primed
are restricted to recognize antigens presented by the MHC
of the immunizing dendritic cells rather than host APCs (7,
9). These observations, when coupled with data that dendritic cells are efficient at capturing protein antigens in an
immunogenic form in situ (10, 11, 12), make it apparent that
these dendritic cells are "nature's adjuvant"
Dendritic cells offer the potential of processing complex
antigens into those peptides that would be presented by self479

MHC products. A possible restriction to this immunizing
potential relates to the fact that in most species and tissues,
dendritic cells are not actively phagocytic. Since endocytosis
is an important means whereby antigens are processed to form
the peptides that are presented on MHC class II products
(13-15), it is not apparent how dendritic cells would present
particle-derived peptides. The paradox is heightened by recent data that phagocytic macrophages do not appear to regurgitate peptides for presentation by dendritic cells (12).
Here we describe an apparent solution to this issue. We
will show that dendritic cells can internalize particulates during
an early stage in their development from proliferating progenitors. Prior work established that the stimulation of bone
marrow suspensions with GM-CSF leads to the production
of clusters of proliferating dendritic cell precursors (16). The
cells that pulse label with [3H]thymidine in the clusters lack
many of the characteristic markers of dendritic cells, e.g., stellate shape and antigenic features like NLDC-145 antigen and
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Summary
Dendritic cells, while effective in sensitizing T cells to several different antigens, show little or
no phagocytic activity. To the extent that endocytosis is required for antigen processing and
presentation, it is not evident how dendritic cells would present particle-associated peptides. Evidence
has now been obtained showing that progenitors to dendritic cells can internalize particles, including
Bacillus Calmette-Guerin (BCG) mycobacteria. The particulates are applied for 20 h to bone
marrow cultures that have been stimulated with granulocyte/macrophage colony-stimulating
factor (GM-CSF) to induce aggregates of growing dendritic cells. Cells within these aggregates
are clearly phagocytic. If the developing cultures are exposed to particles, washed, and "chased"
for 2 d, the number of major histocompatibility complex class II-rich dendritic cells increases
substantially and at least 50% contain internalized mycobacteria or latex particles. The mycobacterialaden, newly developed dendritic cells are much more potent in presenting antigens to primed
T cells than corresponding cultures of mature dendritic cells that are exposed to a pulse of organisms.
A similar situation exists when the BCG-charged dendritic cells are injected into the footpad
or blood stream of naive mice. Those dendritic cells that have phagocytosed organisms induce
the strongest T cell responses to mycobacterial antigens in draining lymph node and spleen.
The administration of antigens to GM-CSF-induced, developing dendritic cells (by increasing
both antigen uptake and cell numbers) will facilitate the use of these antigen-presenting cells
for active immunization in situ.

high levels of M H C class II. In pulse-chase experiments,
[3H]thymidine-labded progeny with all the features of dendritic cells are released. We have found that cells within the
aggregate also are phagocytic, and that in analogous pulsechase protocols, the progeny dendritic cells are dearly labeled
with the phagocytic meal. W h e n the particles are Bacillus
Calmette-Guerin (BCG) 1 organisms, mycobacterial antigens
are presented in a potent manner to T cells in vitro and in situ.

Materials and Methods
Mice. (BALB/c x DBA/2)F1, (C57BL/6 x DBA/2)F1, and

1 Abbreviations used in this paper: BCG, Bacillus Calmette-Guerin; PPD,
purified protein derivative.
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Results
Phagocytosis of Latex Particles within Clusters of Developing
Dendritic Cells: Pulse and Pulse-Chase Protocols. W h e n mouse
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BALB/c male and female mice were purchased from the Trudeau
Institute (Saranac Lake, NY) and Japan SIC (Hamamatsu, Shizuoka)
and used at 6-10 wk of age.
Bone Marrow Culture. As described (16), bone marrow was
flushed from the femurs and tibias, depleted of red cells with 0.83%
ammonium chloride, and nonlymphoid la- cells were cultured in
24-well plates (Nunc, NaperviUe, IL; and 25820; Coming Science
Products, Rochester, NY) at 106 cells per well in 1 ml of RPMI
1640 supplemented with 5% FCS, 20 #g/ml gentamicin, and 1,000
U/ml recombinant murine GM-CSF (9.7 x 107 U/mg; Kirin
Brewery, Maebashi, Gumma, Japan). At 2 d, 0.75 ml of medium
and most of the nonadherent cells were removed and replaced with
fresh medium. This was repeated at days 4-5, thereby removing
most of the developing granulocytes and leaving behind clusters
of proliferating dendritic cells adherent to a stroma that included
scattered macrophages. The culture medium was then supplemented
with particulates, and phagocytosis was allowed to proceed for
20-24 h, usually on days 5-6. At this point the cultures were rinsed
free of loose cells and particles, and the cells were analyzed immediately for particle uptake. Alternatively, cells in the washed cultures were dislodged and 3-4 x 106 cells were transferred to a 60ram petri dish for 1- or 2-d "chase" period in particle-free, fresh,
GM-CSF-supplemented medium. Class II-rich, mature dendritic
cells developed during the chase as described (16), and these were
isolated by cell sorting (below). To compare the phagocytic activity
of developing and mature dendritic cells, particles were also administered to 7-8-d bone marrow cultures that are rich in single
nonproliferating mature dendritic cells.
Particulates. BCG mycobacteria at 1.5-2.5 x 10s CFU/ml
(Trudeau Institute) and 4 x 10s CFU/ml (Kyowa Pharmaceutical
Industries, Tokyo, Japan) were administered at ~107 live BCG per
16-mm diameter well. Uptake was assessed following an "acid-fast"
stain using an auramine-rhodamine procedure (17) that is more sensitive than Ziehl Neelsen and facilitates organism counts. Colloidal
carbon (Pellikan Ink, Hannover, Germany) was added at 1:2,000
dilution. The carbon was identified as a black granular stain in specimens stained with Diff-Quik| (Baxter Healthcare Corp., Miami,
FL). Latex particles (0.5% [vol/vol], 2-#m diameter; Seradyn, Indianapolis, IN) were applied to 1 ml of culture in a 16-mm-diameter
well at 50 #l/well.
Isolation of Mature Dendritic Cells by Cell Sorting. As noted before (16), the dendritic ceils that are produced in GM-CSF-stimulated
bone marrow cultures express very high levels of surface MHC class
II products (mAbs B21-2; TIB 229, and M5/114; TIB 120 from
the American Type Culture Collection [ATCC], Rockville, MD)
as well as moderate levels of a dendritic cell-restricted antigen recognized by mAb NLDC-145 (18). Immediately after the pulse with

BCG, or after an additional 2 d of "chase" culture, the cells were
stained with biotin B21-2 and FITC-streptavidin (Tago, Burlingame,
CA). Class II-rich cells then were sorted (FACStar Plus| Becton
Dickinson Immunocytometry Systems, San Jose, CA) and cytospun
onto glass slides (Shandon Southern Instruments Inc,, Sewickley,
PA). Sorted cells were stained with Diff-Quick| (Baxter Healthcare Corp.), which outlines the stellate shape of dendritic cells in
cytospins and allows enumeration of profiles containing perinuclear
depots of internalized colloidal carbon or latex spheres. To visualize
BCG, the cytospins were fixed in absolute acetone for 10 rain at
room temperature and stained with M5/114 anti-class II, NLDC145 anti-dendritic cell (18), or RA3-6B2 anti-B220 or anti-B cell
(the latter as a control) followed by POX-conjugated mouse anti-rat
Ig (Boehringer Mannheim Biochemicals, Indianapolis, IN) and diaminobenzidine tetraHC1 (Polyscience Inc., Warrington, PA). The
preparations were then double labeled for acid-fast bacilli with auramine rhodamine (17). Virtually all the cells in the preparation were
rich in NLDC-145 and MHC class II products. The numbers of
BCG bacilli in at least 400 cells were enumerated.
Electron Microscoff/(EM). To prove that cell-associated BCG were
all internalized, the dendritic cells produced in pulse-chase protocols
(above) were fixed in 2.5% glutaraldehyde and processed for EM
as described (16).
Antigen Presentation In Vitro. Mice were primed with CFA
(Sigma Chemical Co., St. Louis, MO), 25 #1 in the fore and rear
paws, or, as a control, mycobacteria-free IFA. 1-2 wk later, the
draining lymph nodes were dissociated into a single-cell suspension and depleted of APCs with mAbs to MHC class II, B220,
and heat-stable antigens (M5/114 anti-Ia, RA3-6B2 anti-B220, and
Jlld anti-HSA; TIB 120, 146, and 183 from the ATCC, respectively) and rabbit complement. 3 x 10s of these APC-depleted,
primed T cells were cultured in 96-well flat-bottomed microtest
wells (Nunc; or 25860; Corning Science Products) in Click's
medium (Irvine Scientific, Santa Ana, CA) supplemented with 0.5%
normal mouse serum, 20 #g/ml gentamicin, 50 #M 2-ME, 2 mM
glutamine, and 1 mM sodium pyrnvate (Gibco Laboratories, Grand
Island, NY). Graded doses of BCG-pulsed, bone marrow or spleen
APCs were added (see Results). 1 #Ci of [3H]thymidine (20
Ci/mmol, 4 #Ci/ml; New England Nuclear, Boston, MA; or 15
Ci/mmol, 4 #Ci/ml; American Radiolabeled Chemicals Inc., St.
Louis, MO) was added to monitor DNA synthesis at times indicated in the legends. Data shown are means of triplicates in which
SDs were <15% of the mean.
Antigen Presentation In Viv~ APCs that had been pulsed with
antigen in vitro were administered in vivo to unprimed (CxD2)Fj
mice. To prime T cells in draining lymph node, 2 x 1@ dendritic
cells were injected into the paws and node cell suspensions were
prepared 5 d later (7). To prime T cells in spleen, 10~ cells were
injected intravenously and splenocytes were prepared 5 or 10 d later.
To measure T cell priming, bulk lymph node or spleen cells were
cultured as above and challenged with graded doses of protein
antigens, either purified protein derivative (PPD; Statensernm Institute, Copenhagen, Denmark, or Dr. Ichiro Toida, Research
Institute for BCG in Japan, Kiyose, Tokyo), or BSA, and [3H]thymidine uptake was measured at 48-64 h. To characterize the proliferating cells, the populations were treated with antibodies and
complement before measuring [3H]thymidine uptake.

acteristic stdlate shapes and high levels of MHC dass II and
NLDC-145 antigens (16). When the released cells were examined by light microscopy, many contained latex spheres
that were often around a clear perinuclear zone or centrosphere
(Fig. 1 B). We also studied colloidal carbon uptake in a similar
manner. When aggregates were pulsed with colloid and mature dendritic cells were allowed to form during a chase period,
some of the released cells had a centrosphere with small but
clear-cut carbon deposits (Fig. 1 C). In contrast, when latex
or carbon was offered to mature dendritic cells, little uptake
took place (Fig. 1 D).

BCG Uptake by Developing Dendritic Cells: Acid-fast Stains.
The same protocols were repeated, but now preparations with
live BCG mycobacteria were administered as the phagocytic
meal. Cell-associated bacilli were visualized by a sensitive
fluorescent acid-fast stain. After the 20-h pulse, the developing
dendritic cell aggregates were again strongly labeled. To iso-

Figure 1. Diff-Quick stains of developing dendritic cells that have been exposed to Latex and carbon. (A) An aggregate of developing dendritic
cells cytospun after a 20-h exposure to 2-/zm latex spheres. Many cells in the aggregate are labeled with the uniform latex particles (arrows). x 270.
(B) Same as A, but the cultures were chased for 1 d to allow the production of mature single dendritic cells. Many of the released dendritic cells
contain the uniform and lucent latex spheres (arrows). x675. (C) Same as A and B, but the aggregates were pulsed with colloidal carbon and then
chased for 1 d in carbon-free medium. The centrospheres of some of the mature dendritic cells that release from the aggregate contain small but clear-cut
endocytic granules of black, indigestible phagocytic tracer (arrows). • 675. (D) Mature dendritic cells were exposed to carbon after they had been produced
from proliferating aggregates. Few if any carbon deposits are evident. •
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blood or bone marrow is stimulated with GM-CSF, proliferating cell aggregates appear, and these give rise to large
numbers of typical immunostimulatory dendritic cells (16,
19). In bone marrow, which was used for the experiments
described below, the proliferating aggregates are best identified
by washing away the majority of nonadherent granulocytes
that are also induced by GM-CSF in the cultures (16). At
days 5-6, the time point when the aggregates were first sizable (5-10 cells wide), we applied different particles over a
20-22-h period.
After administration of 2-/zm latex spheres, heavy labeling
was noted in scattered macrophages on the monolayer. In
addition, some clear labeling occurred within the developing
dendritic cell aggregates (Fig. 1 A). Aggregates that had been
exposed to particles were recultured an additional 2 d. During
this time, large numbers of cells were released into suspension. These primarily were mature dendritic cells with char-

Table 1. Frequencyof Dendritic Cells with PhagocytosedBCG

Organisms in GM-CSF-stiraulated Mouse Bone Marrow Cultures
Exp.

BCG
exposure

No. of
Phagocytic
cells counted
cells
BCG/DC

1

Days 5-6 pulse

469
498

%
18.1
18.5

2

Days 5-6 pulse

444
463
564
579

22.5
22.2
57.1
57.0

3.0
2.9
3.8
3.2

440
623
487
511

21.8
22.8
50.3
58.7

2.1
2.9
2.9
4.0

Pulse, 2-d chase
3

Days 5-6 pulse
Pulse, 2-d chase

2.6
2.5

Quantitative data of dendritic cells containing BCG. Mouse bone marrow cultures were stimulated in 16-mm wells for 5 d with GM-CSF,
washed, and exposed to BCG organisms for 20 h. The cultures were
washed again and either examined immediately, or pooled and transferred
to a 60-mm dish for an additional 2-d chase culture. The dendritic cells
in the cultures were selected as h-rich cells using a cell sorter and then
spun onto glass slides for staining for acid-fast bacilli. During the chase
period, the percentage of h-rich cells in the cultures increased 2-2.5-fold,
and the total number of cells increased twofold, so that the number of
h-rich cells increased four to five times.
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cell centrosphere. It appeared that a phagosomal membrane
closely approximated most bacilli (Fig. 3 C and D).

Presentation In Vitro of Mycobacterial Antigens to Primed T
Cells. To test the presenting function of dendritic cells that
had been pulsed or pulse chased with BCG organisms, we
first prepared antigen-responsive T cells from the draining
lymph nodes of mice that had been injected with CFA that
contains heat-kiUed mycobacteria or with IFA as control (see
Methods). When dendritic cells were added to IFA-primed
T cells, a syngeneic mixed leukocyte reaction was observed.
This was comparable whether or not the APCs had been exposed to BCG (Fig. 4, right). However, when dendritic cells
had been pulsed with BCG and were added to CFA-primed
T cells, strong proliferative responses were induced (Fig. 4,
left). If dendritic cells were tested immediately after the 1-d
pulse, or after an additional 2-d chase period, the chased population was much more potent (Fig. 4, left, compare diamonds
with inverted triangles). As few as 100 BCG pulse-chased dendritic cells elicited sizable T cell responses in vitro (Fig. 4
left, diamonds). The BCG-pulse-chased populations also were
5-10 times more potent in inducing responsiveness to mycobacterial antigen than mature dendritic cells freshly exposed to
either PPD or BCG (Fig. 4, left, compare diamonds with circles
and triangles). Therefore, it appeared that the extent of phagocytosis correlated with the efficacy of presentation, as the pulsechased populations were the most active APCs and contained
the most intracellular BCG (Table 1).

Presentation In Vivo of MFobacterial Antigens to Unsensitized
Mice. Comparable populations of BCG-pulsed, and BCGpulsed and chased, APCs were tested for the capacity to present
mycobacterial antigens to unprimed mice. After injection into
the footpads, strong responsiveness to PPD was observed (Fig.
5). Again, the dendritic cells were the most potent if tested
after a 2-d chase (Fig. 5; compare open diamonds with open
triangles), and this chase period greatly increased the total yidd
of dendritic cells (16).
To test if the increased antigen-presenting function of BCG
pulse-chased dendritic cells was related to the increased number
of APCs carrying BCG, the primed populations were also
tested for responsiveness to BSA, since the dendritic cells had
been grown in the presence of FCS. All the dendritic cell
populations, regardless of the details of the exposure to BCG,
primed mice similarly to BSA (Fig. 5, filled symbols). This
indicates that each population was comparably ef~cient in
immunizing to a soluble protein, whereas the dendritic cells
that had phagocytosed BCG were more effective in eliciting
responses to mycobacterial antigens.
The surface markers of the primed cells were tested by
antibody- and complement-mediated lysis of the populations
before measuring [3H]thymidine uptake (data not shown).
The proliferating cells were Thy-1, but negative for MHC
class II, heat-stable antigen, and B220. Anti-CD4 hybridoma
culture supernatant blocked proliferation ~>85%, i.e., the
primed cells were Th cells.
Priming was also observed when spleen T cells were tested
after an intravenous infusion of BCG-pulsed and BCG
pulse-chased dendritic cells (Fig. 6). The cells were more
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late the more mature dendritic cells from the cultures, we
resuspended the cells and sorted those with high levels of
MHC class II products. Immediately after the BCG pulse,
,,o20% of the sorted cells contained acid-fast bacilli (Table
1). It was difficult to separate the majority of MHC class
II-weak cells because of excessive stickiness during cell sorting.
Companion cell cultures were then studied after 2 d of
a chase culture. Because many mature dendritic cells formed
during the chase period, the number of Ia-rich progeny had
increased fourfold (Table 1). About 50% of these progeny
contained BCG, usually in a perinudear location (Table 1
and Fig. 2). Double labeling experiments verified that the
cells containing acid-fast bacilli expressed MHC class II and
the dendritic cell-restricted NLDC-145 antigen (Fig. 2). Because the total number of MHC class II- and NLDC-145positive cells had also increased fourfold in just 2 d, it is likely
the these BCG-laden dendritic cells were derived from less
mature but phagocytic progenitors in the aggregates.
Electron Microscotv of BCG-pulsed APCs. The perinuclear
location of the cell-associated particles by light microscopy
indicated that organisms had been internalized. The matter
was verified by dectron microscopy. Most of BCG organisms
were identified intracellularly. All call-associated BCG were
identified within intracellular vacuoles dose to the Golgi complex (Fig. 3, A and B). Typically only one or two badlli could
be identified within any one section through the dendritic

responsive at 5 vs. 10 d after injection (compare Fig. 6, A
with C). Again dendritic cells that had been cultured
("chased") for 2 d after exposure to BCG were the most potent (Fig. 6, compare filled diamonds with filled triangles), but
all populations primed the spleen cells similarly to BSA (Fig.
6 B). We conclude that dendritic cell progenitors capture and
retain mycobacterial antigens in a manner that is highly immunogenic in vivo.
Discussion

Particle uptake is a specialized activity of mononuclear and
polymorphonudear phagocytes. Dead cells, immune complexes, and microorganisms all are avidly internalized. After
fusion with hydrolase-rich lysosomes, the ingested particles
are degraded (20, 21). This degradation must be at the level
of permeable amino acids (22, 23) and saccharides, otherwise
the vacuolar apparatus would swell with indigestable materials
(24, 25). Such dearance and digestive functions of phagocytes contribute to wound healing, tissue remodeling, and
host defense.
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Another consequence of endocytosis, the processing of antigens by APCs differs in many respects from the scavenging
function of phagocytosis. (a) Processing required the generation of peptides at least 8-18 amino acids in length (26, 27),
while scavenging entails digestion to amino acids (22, 23).
(b) Presentation requires the binding of peptides to MHC
class II products, possibly preferentially to newly synthesized
class II (28, 29), whereas scavenging does not require MHC
products. (c) Antigen presentation can function at a low capacity, since only a few hundred molecules of ligand need
to be generated for successfulstimulation of certain T-T hybrids
(30, 31) and most likely primary T cell populations (32).
During scavenging, phagocytes readily clear and destroy
hundreds of thousands of protein molecules each hour (23).
(d) Antigen presentation is best carried out by cells that are
rich in MHC class II but show little phagocytic activity and
few lysosmes, i.e., dendritic cells and B cells, whereas phagocytes (macrophages and neutrophils) often have low levels of
class II and abundant lysosomes. These observations, together
with the identification of antigenic specializations within the
endocytic system of dendritic cells and B cells (33, 34), have
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Figure 2. Uptake of BCG into developing dendritic cells using two-color labels for acid-fast bacilli and dendritic cell antigens. Clusters of developing
dendritic ceils (6-d marrow cultures induced with GM-CSF) were exposed for 20 h to BCG. The monolayers were washed and chased in medium
with GM-CSF for 2 d. The cells were dissociated, hbded with FITC-anti-I-A mAb, and the class II-rich cells were isolated by cell sorting (most
of the ceils in the culture are class II rich) as shown previously (16). The sorted ceils were cytospun, stained with auramine-thodamine to visualize
the cell-associatedBCG (B and D), and double labded with a different mAb and immunoperoxidase (,4 and C). Arrows on the left indicate the location
of the bacilli. The peroxidase label for anti-class II (I-A and I-E, M5/114) outlines the dendritic cell processes (C) much better than the label for the
dendritic cell-restricted NLDC-145 antigen (.4). The brown reaction product in the color version of A corresponds to the dense black deposits in
the black and white version that is shown, x600.

led to the suggestion that the machinery required for antigen
presentation may differ from that required for scavenging,
both quantitatively and qualitatively (7). Nevertheless, how
do APCs that are not phagocytic (B cells and dendritic cells)
present peptides derived from particulates?
In the case of dendritic cells, there have been indications
that these APCs are at some point capable of phagocytic activity. Pugh et al. (35) noted Feulgen-stained inclusions in
some afferent lymph dendritic cells and suggested that phagocytosis of other cells had taken place before entry into the
lymph (35). Fossum and Rolstad (36) noted phagocytic inclusions in the interdigitating dendritic cells of the T cell
areas in mice that were rejecting allogeneic leukocytes. Reis
484

e Sousa et al. (37) found that freshly isolated epidermal Langerhans cells, which are immature but nonproliferating dendritic cells, can internalize small amounts of certain particulates. Here we show that clear-cut phagocytosis occurs when
particles are administered to cultures of proliferating dendritic
cells. If particles are fed to progenitor populations, phagocytic activity is expanded both qualitatively, i.e., many dendritic cell progeny carry a particulate meal, and quantitatively,
i.e., the numbers of such cells are greatly increased.
The number of particles ingested by developing dendritic
cells is small relative to typical phagocytes, and the rate of
uptake is slow. For example, after a 4-h pulse there is relatively little labeling of dendritic cell precursors in the de-
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Figure 3. Electronmicroscopyof BCG in dendritic cells. As in Fig. 2, BCG was added to GM-CSF-stimulated6-d bone marrow cultures for I d.
After washing and an additional 2 d of culture, the releasedcells were processedfor electron microscopy.(A and B) Low-powerviews to show the
typical dendritic cells with numerous processesand a few phagocytosedBCG (white arrows), x 5,400 (A); x 3,900 (B). (C and D) Higher power views
to show phagosomal membranes against the BCG, as well as organelles of the dendritic cell centrosphere, including endocytic vacuoles (E), Golgi
apparatus (GA), and small vesicleswith a dense core (A). x20,000 (C); x15,000 (D).
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Figure 4. Antigen presentation to CFA-primed/
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or IFA. The different APCs are listed. Mature dendritic cells are day 8 bone marrow cultures, and immature dendritic cells are from day 5-6 cultures.
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veloping aggregates, while there is active uptake by macrophages on the monolayer. Nonetheless, the administration
of particulate meals (latex and BCG) to developing cultures
leads to clear-cut phagocytosis by these specialized APCs.
Some sense of the immunogenicity of the ingested particles was obtained with BCG mycobacteria (Figs. 4-6). In
any inoculum of the BCG vaccine, there are live bacilli
(•50% of the bacilli act as CFU), dead bacilli, and probably
a number of mycobacterial proteins. We suspect that the
phagocytosed pool of BCG is being presented because of ob-

servations comparing the presentation of mycobacterial antigens with BSA, a component of the serum in which the
dendritic cells are grown. Whereas dendritic cells that are
pulsed and chased with BCG are the most effective APCs
for mycobacteria (Figs. 5 and 6, diamonds) and contain the
most particles, all the APC populations were comparable in
presenting BSA. This implies that BCG particle uptake accounts for the bulk of the mycobacterial priming. One can
now undertake a study wherein dendritic cells are evaluated
for their capacity to induce host resistance to mycobacteria
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Figure 5. Antigen presentation to naive
node T cells in situ. Growing cultures of bone
marrow dendritic cells were pulsed with BCG
at days 5-6, and used immediately or after a
2-d chase culture. The populations were injected
into the paws of naive mice without artificial
adjuvants. 5 d later the draining lymph nodes
were taken and stimulated in vitro with graded
doses of PPD and BSA (the dendritic cells had
been grown with FCS), with the BSA serving
as a nonparticuhte antigen. Data are means and
SDs for groups of five mice, each studied
separately. Control lymph nodes did not respond to PPD or to BSA (<2,000 cpm).
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infection, a matter of some import given the need to develop
better vaccination and treatment protocols for tuberculosis,
including the drug-resistant variety.
In effect, the pulse and chase protocol that we have used
to charge developing dendritic cells with organisms in the
BCG vaccine allows the two broad components of immunostimulation to take place sequentially. These components are: (a) antigen capture and presentation, here the capture of particulates, by immature dendritic cells; and (b)
development of potent accessory or immunostimulatory functions during the chase period. The situation is comparable
to that seen in the handling of soluble proteins (29, 38) and
particles (37) by epidermal Langerhans cells. Each of the two
broad components of APC function entails many subcomponents. For example, immature dendritic ceUs not only are
more phagocytic but display other features needed for antigen presentation such as active biosynthesis of abundant
MHC class II molecules and invariant chain (29, 39) and
numerous acidic endocytic vacuoles (40).
The capacity to charge APCs with antigens in pulse-chase
protocols may be a spedal feature of dendritic cells. Prior studies
with macrophages and B cells had suggested that T cell epitopes are short lived (41). The results reported here and elsewhere (7, 29, 32) indicate that immunogenic peptides can
be long lived on dendritic cells at least 2 d before injection
into mice. This retention capacity should enable dendritic
cells to migrate and sensitize T cells in draining lymphoid
tissues over a several-day period (7-9).
In this paper bone marrow was used as a ready source of
GM-CSF-responsive, proliferating dendritic cell precursors
(16). Similar progenitors are found in many other tissues (Inaba
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et al., manuscript in preparation) and in the blood itself (19).
If progenitors are widely distributed, dendritic cells may acquire particulates whenever and wherever their proliferation
and/or maturation is induced. The host may thereby generate
in vivo sizable numbers of potent APCs that have successfully processed particulate antigens in that locale.
In the case of BCG, the bulk of the primed cells are
CD4 + T cells, most likely because the antigenic load is handled by the endocytic pathway and MHC class II products
(15). An important feature of dendritic cells is the capacity
to efficiently present microbial and other antigens on both
class I and II products. In the case of influenza, it has been
found that the class I pathway for inducing CD8 + CTL requires adequate delivery of antigen (infectious virus) into the
cytoplasm, whereas the purely endocytic pathway delivers
noninfectious virions for presentation to CD4 + helpers (42).
Developing dendritic cell cuhures provide an opportunity for
charging MHC class I products with peptide, since ceU proliferation allows various methods of gene insertion (as with
retroviral vectors) to be applied.
By using developing dendritic cells to charge MHC class
I and/or II products, several desirable components of T call
modulation in situ can be achieved. One brings about antigen uptake and presentation with immature progenitors,
allows the APC to tailor the peptides that are appropriate
for an individual's MHC products, and increases the numbers
of specialized stimulatory APCs. These properties of dendritic cell progenitor populations meet many of the demands
for using cells as vehicles for active immunization and immunotherapy in situ.
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to naivespleencellsin situ. Growing
cultures of bone marrowdendritic
cellswerepulsedwith BCG at days
5-6 (immature),at days 7-8 (mature), or at days5-6 followedby a
2-d chase. 106 cells were injected
intravenouslyinto groups of mice.
5 or 10d later, the spleencellswere
culturedin vitro with gradeddoses
of PPD or BSAas antigen.Sincethe
dendriticcellswereculturedin FCS,
the use of BSA servesas controlto
ensure that all dendriticcell populations were comparablyimmunogenicin vitro. Unprimedspleendid
not respondto eitherBSAor PPD.
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